Review: Therapeutic drug monitoring in pediatrics

Therapeutic Drug Monitoring

Volumn 24, Issue 1, 2002, Pages 1-8

  Soldin, Offie Porat ^a   Soldin, Steven J ^a  

^a Consul Epidemiol/Occup Hlth Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; ANTICONVULSIVE AGENT; CAFFEINE; CARBAMAZEPINE; CHLORAMPHENICOL; CLOMIPRAMINE; DIGOXIN; DISOPYRAMIDE; ETHOSUXIMIDE; GENTAMICIN; IMIPRAMINE; LIDOCAINE; METHOTREXATE; MICROSOME ENZYME; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROCAINAMIDE; PROPRANOLOL; QUINIDINE; THEOPHYLLINE; TOBRAMYCIN; VALPROIC ACID;

AGE; APNEA; BODY COMPOSITION; CHRONOPHARMACOLOGY; CONFERENCE PAPER; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; ENURESIS; HUMAN; KIDNEY CLEARANCE; PEDIATRICS; PREMATURITY; PRIORITY JOURNAL; SEIZURE; STOMACH PH;

ABSORPTION; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG MONITORING; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PROTEIN BINDING;

EID: 0036150387     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200202000-00001     Document Type: Conference Paper

References (47)

1. Best practice in therapeutic drug monitoring
2. Drug therapy for ambulatory pediatric patients in 1979
3. Mechanisms of drug absorption and their development
4. Clinical pharmacology and therapeutic drug monitoring in neonates and children
5. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
6. Recommendations for bioequivalence testing of cyclosporine generics revisited
7. Clinical pharmacokinetics in neonates
8. Aging effects and drugs in man
9. Genetic control of the phenobarbital-induced shortening of plasma half-lives in man
10. Therapeutic drug monitoring and clinical toxicology in a pediatric hospital
11. Phenytoin
12. Pharmacokinetic aspects of theophylline in premature newborns
13. Pharmacokinetics of theophylline: Application to adjustment of the clinical dose of aminophylline
14. Clinical significance of drug binding to orosomucoid
15. Dependence of neonatal drug binding on a acid glycoprotein concentration
16. Free drug measurements: Methodology and clinical significance
17. Free drug measurements. When and why? An overview
18. Therapeutic monitoring in saliva
19. Therapeutic drug monitoring in pediatric practice
20. Acute digoxin overdose in a newborn with renal failure: Use of digoxin immune Fab and peritoneal dialysis
21. Determination of free digoxin concentration in digoxin toxic patients after administration of digoxin Fab antibodies
22. Chronopharmacology
23. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: Better in the evening
24. Pharmacokinetic case for giving 6-mercaptopurine maintenance doses at night
25. Diurnal changes in the pharmacokinetic behavior of amikacin
26. Routine methods in toxicology and therapeutic drug monitoring by high-performance liquid chromatography 6; a rapid microscale method for determination of caffeine in plasma and saliva
27. Severe side effects and drug plasma concentrations in preterm infants treated with doxapram
28. Caffeine enzyme immunoassay in neonatal and pediatric drug monitoring
29. Organization and efficacy of a therapeutic drug monitoring consultation service in a pediatric hospital
30. Therapeutic drug monitoring: Does it benefit the patient?
31. Optimization of a therapeutic drug monitoring program
32. Strategies for physician education in therapeutic drug monitoring
33. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment
34. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates
35. Antiepileptic drug levels quality control program: Interlaboratory variability
36. Characterization of cross-reactivity by carbamazepine 10,11-epoxide with carbamazepine assays
37. Immunophilins: Their properties and their potential role in therapeutic drug monitoring
38. Are immunoassays for digoxin reliable?
39. An immunophilin-binding assay for sirolimus
40. The qualification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients
41. On the significance of host factors that affect drug disposition
42. Therapeutic drug monitoring of antiretroviral drugs
43. Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection
44. Simultaneous measurement of 14 AIDS drugs by tandem-MS
45. Antiretrovirals: Simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography-mass spectrometry assay
46. Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics